A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.
Clinical trial NCT00219128 · COMPLETED
Trial details
- NCT number
- NCT00219128
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2005-06-01
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.